Patent · US Active

Combination of checkpoint kinase 1 inhibitors and WEE 1 kinase inhibitors

US9370567B2 · kind B2 · utility

1Cited by
6References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2011
Grant dateJun 21, 2016
Priority date—
Expiry dateJan 25, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A combination of a CHK1 inhibitor and a WEE1 inhibitor are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.